Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $72.04 USD
Change Today +1.49 / 2.11%
Volume 6.5M
MYL On Other Exchanges
Symbol
Exchange
NASDAQ GS
Munich
As of 5:20 PM 05/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Randall L. Vanderveen Ph.D., B.C.P.P., F.A.Ph.A., F.A.S.H.P., R.Ph.

Non-Executive Director, Member of Compliance Committee and Member of Science and Technology Committee, Mylan N.V.
AgeTotal Calculated CompensationThis person is connected to 12 board members in 1 different organizations across 1 different industries.

See Board Relationships
63$301,121

Background*

Dr. Randall L. Vanderveen, also known as Pete, Ph.D., BCPP, FAPhA, FASHP, R.PH., has been Dean and John Stauffer Chair of the University of Southern California School of Pharmacy since September 2005. Dr. Vanderveen has served as Consultant and Advisor to McKesson, Rite Aid, Eckerd, Walgreens, Bristol-Meyers Squibb, UpJohn, Merck, and Pfizer Pharmaceuticals. Dr. Vanderveen has also served as a Consultant to the Oregon Medical Assistance Program, the Michigan Department ...

Read Full Background

Corporate Headquarters*

Albany Gate
Potters Bar, Hertfordshire EN6 1AG

United Kingdom

Phone: 44 1707 853000
Fax: 44 1707 643148

Board Members Memberships*

2002-Present
Non-Executive Director, Member of Compliance Committee and Member of Science and Technology Committee

Education*

MS
Purdue University
BS
Purdue University
PhD
Michigan State University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$86,125
Total Calculated Compensation$301,121
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MYL:US $72.04 USD +1.49

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Vincent A. Forlenza BDChairman, Chief Executive Officer, President and Chairman of Executive Committee
Becton, Dickinson and Company
$985.0K
James T. Ryan Chairman, Chief Executive Officer and President
W.W. Grainger, Inc.
$1.1M
Joseph C. Papa Chairman, Chief Executive Officer and President
Perrigo Company Public Limited Company
$1.1M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$3.6M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
¥170.0M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MYLAN NV, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.